The differential impairment of agonist-induced platelet aggregation has been shown to be indicative of further hereditary thrombocytopenias associated with platelet function defects, including WAS, GPS, GFI1-related thrombocytopenia, ARC syndrome, and Stormorken syndrome [5,40,77]. This evidence concerns the gene NBEAL2 and Thrombocytopenia.